This narrative review explores phosphoproteomics technologies as a potential tool for improving disease diagnosis and treatment. The authors gathered existing information to discuss how these methods might work in a medical setting. No specific patient groups or sample sizes were reported in this summary of the literature.
The review highlights that these technologies could help doctors see details about diseases that were previously hard to detect. However, the authors point out several challenges that currently limit how well these tools can be used. One major issue is that the technology struggles to detect very low levels of certain signals. Another problem is that single-cell versions of these tools have limits on how many samples they can process at once.
Finally, the review notes that there are no standardized workflows for using these technologies yet. Because the evidence comes from a narrative review rather than a large clinical trial, readers should view these findings as early insights. The technology is not ready for immediate use in standard care, but it shows promise for future research.